retatrutide now has Phase 3 data but limited post-market experience Heart rate : Retatrutide shows small increases
What the drug does for a person taking it purely for weight loss, with no such history, is a related but separate question one on which the evidence is thinner
Meta-analyses suggest potential cognitive protection at a population level (Cukierman-Yaffe et al., 2025)
In December 2014, the FDA approved liraglutide as a weight loss drug
Related Content FDA approves painkiller made by Sun Pharmaceutical Industries MUMBAI, India The Food and Drug Administration has approved a generic painkiller made by Sun Pharmaceutical Industries, Sun said
Intensive training programs, restricted diets during cutting phases, and the use of certain supplements or medications can all impact B12 status